← 產業報告目錄

Europe Pen Needles Market Research Research Report - Forecast to 2032

出版商 Market Research Future產業別 Medical Devices出版日期 2024-03-21頁數 104報告編號 MRF-9dc8929c0d

授權報價

Single User Price$2,950 USD
Multi User Licence (up to 10 users)$3,950 USD
Enterprisewide Price (Global Site License)$5,250 USD
洽詢購買 申請 Sample

報告摘要

Europe Pen Needles Market Research Report Forecast to 2032 Market Overview Europe Pen Needles Market is anticipated to register a significant CAGR of 8.61% by 2032. A pen needle is a medical device used in conjunction with injection pens to administer medications by subcutaneous injection. Injection pens are commonly used for the self-administration of insulin by individuals with diabetes, as well as for other injectable medications. Pen needles are attached to the injection pen and are designed to deliver the medication beneath the skin. The Europe pen needle market is predicted to expand due to increasing prevalence of diabetes, obesity, and other chronic diseases rising awareness of self-administration, and patient preference for pen devices, However, regulatory challenges is limiting market expansion. technological innovation and patient-centric solutions on the other hand, boosts the market's attractiveness. The Europe pen needle market has experienced notable expansion, driven significantly by the rising awareness of self-administration of injectable medications. Market Segmentation Based on brand, the Europe pen needles market has been segmented into standard pen needle and safety pen needle. The standard pen needle segment held the largest market in 2022 and is the fastest growing segment during the forecast period. Based on needle length, the Europe pen needle market has been segmented into 4mm, 5mm, 6mm, 8mm, 10mm and 12.7mm. The 4mm segment held the largest market in 2022 and is the fastest growing segment during the forecast period. Based on application, the Europe pen needle market has been segmented into insulin therapy, GLP-1 therapy, growth hormone therapy, osteoporosis, and others. The insulin therapy segment held the largest market in 2022 and is the fastest growing segment during the forecast period. Based on distribution channel, the Europe pen needle market has been segmented into direct sales and distributors. The distributors segment held the largest market in 2022 and is the fastest growing segment during the forecast period. Based on end user, the Europe pen needle market has been segmented into hospitals & clinics, homecare settings, and others. The homecare settings segment held the largest market in 2022 and is the fastest growing segment during the forecast period. The Europe pen needles market is segmented into the France and Rest of Europe. The Rest of Europe held the largest market share of 82.99% based on region and is anticipated to dominate the overall needle pen market during the forecast period. Major Players The key players operating in the market are Novo Nordisk A/S, Terumo Corporation, Embecta Corp., Ypsomed Holdings AG, MTD Medical Technology and Devices, Novo Nordisk A/S, Terumo Corporation, Embecta Corp., Ypsomed Holdings AG, and MTD Medical Technology and Devices.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 13 2 MARKET INTRODUCTION 15 2.1 DEFINITION 15 2.2 SCOPE OF THE STUDY 15 2.3 RESEARCH OBJECTIVE 15 2.4 MARKET STRUCTURE 16 3 RESEARCH METHODOLOGY 17 3.1 OVERVIEW 17 3.2 DATA FLOW 19 3.2.1 DATA MINING PROCESS 19 3.3 PURCHASED DATABASE: 20 3.4 SECONDARY SOURCES: 21 3.4.1 SECONDARY RESEARCH DATA FLOW: 22 3.5 PRIMARY RESEARCH: 23 3.5.1 PRIMARY RESEARCH DATA FLOW: 24 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED 25 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 26 3.6.1 REVENUE ANALYSIS APPROACH 26 3.7 DATA FORECASTING 27 3.7.1 DATA FORECASTING TECHNIQUE 27 3.8 DATA END USERLING 28 3.8.1 MICROECONOMIC FACTOR ANALYSIS: 28 3.8.2 DATA END USERLING: 29 3.9 TEAMS AND ANALYST CONTRIBUTION 31 4 MARKET DYNAMICS 33 4.1 INTRODUCTION 33 4.2 DRIVERS 34 4.2.1 INCREASING PREVALENCE OF DIABETES, OBESITY, AND OTHER CHRONIC DISEASES 34 4.2.2 RISING AWARENESS OF SELF-ADMINISTRATION 34 4.2.3 PATIENT PREFERENCE FOR PEN DEVICES 34 4.3 RESTRAINTS 35 4.3.1 REGULATORY CHALLENGES 35 4.4 OPPORTUNITY 37 4.4.1 TECHNOLOGICAL INNOVATION AND PATIENT-CENTRIC SOLUTIONS 37 5 MARKET FACTOR ANALYSIS 38 5.1 VALUE CHAIN ANALYSIS 38 5.1.1 R&D 39 5.1.2 MANUFACTURING 39 5.1.3 DISTRIBUTION AND SALES 39 5.1.4 POST-SALES MONITORING 40 5.2 PORTER’S FIVE FORCES MODEL 40 5.2.1 THREAT OF NEW ENTRANTS 41 5.2.2 BARGAINING POWER OF SUPPLIERS 41 5.2.3 THREAT OF SUBSTITUTES 41 5.2.4 BARGAINING POWER OF BUYERS 41 5.2.5 INTENSITY OF RIVALRY 41 5.3 IMPACT OF COVID-19 ON THE EUROPE PEN NEEDLE MARKET 42 5.3.1 IMPACT ON SUPPLY CHAIN 42 5.3.2 IMPACT ON KEY PLAYERS 42 5.3.3 IMPACT ON DEMAND AND SUPPLY 42 6 EUROPE PEN NEEDLES MARKET, BY PRODUCT 45 6.1 OVERVIEW 45 6.2 STANDARD PEN NEEDLE 46 6.3 SAFETY PEN NEEDLE 47 7 EUROPE PEN NEEDLES MARKET, BY NEEDLE LENGTH 48 7.1 OVERVIEW 48 7.2 4MM 50 7.3 5MM 50 7.4 6MM 51 7.5 8MM 51 7.6 10MM 51 7.7 12.7MM 52 8 EUROPE PEN NEEDLE MARKET, BY APPLICATION 53 8.1 OVERVIEW 53 8.2 INSULIN THERAPY 56 8.3 GLP-1 THERAPY 56 8.4 GROWTH HORMONE THERAPY 56 8.5 OSTEOPOROSIS 57 8.6 OTHERS 57   9 EUROPE PEN NEEDLE MARKET, BY DISTRIBUTION CHANNEL 58 9.1 OVERVIEW 58 9.2 DIRECT SALES 59 9.3 DISTRIBUTORS 59 10 EUROPE PEN NEEDLE MARKET, BY END USER 61 10.1 OVERVIEW 61 10.2 HOSPITALS & CLINICS 62 10.3 HOMECARE SETTINGS 63 10.4 OTHERS 63 11 EUROPE PEN NEEDLE MARKET, BY REGION 64 11.1 OVERVIEW 64 11.2 EUROPE 64 11.2.1 FRANCE 67 11.2.2 REST OF EUROPE 69 12 COMPETITIVE LANDSCAPE 72 12.1 INTRODUCTION 72 12.2 MARKET SHARE ANALYSIS, 2022 72 12.3 COMPETITOR DASHBOARD 73 12.4 PUBLIC PLAYERS STOCK SUMMARY 74 12.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 74 12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 75 12.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL 75 13 COMPANY PROFILES 76 13.1 NOVO NORDISK A/S 76 13.1.1 COMPANY OVERVIEW 76 13.1.2 FINANCIAL OVERVIEW 77 13.1.3 PRODUCTS OFFERED 77 13.1.4 KEY DEVELOPMENTS 78 13.1.5 SWOT ANALYSIS 78 13.1.6 KEY STRATEGIES 79 13.2 TERUMO CORPORATION 80 13.2.1 COMPANY OVERVIEW 80 13.2.2 FINANCIAL OVERVIEW 81 13.2.3 PRODUCTS OFFERED 81 13.2.4 KEY DEVELOPMENTS 82 13.2.5 SWOT ANALYSIS 82 13.2.6 KEY STRATEGIES 82 13.3 NIPRO EUROPE GROUP COMPANIES 83 13.3.1 COMPANY OVERVIEW 83 13.3.2 FINANCIAL OVERVIEW 83 13.3.3 PRODUCTS OFFERED 84 13.3.4 KEY DEVELOPMENTS 84 13.3.5 SWOT ANALYSIS 84 13.3.6 KEY STRATEGIES 84 13.4 SHANGHAI BEIPU MEDICAL CO., LTD. 85 13.4.1 COMPANY OVERVIEW 85 13.4.2 FINANCIAL OVERVIEW 85 13.4.3 PRODUCTS OFFERED 85 13.4.4 KEY DEVELOPMENTS 85 13.4.5 KEY STRATEGIES 86 13.5 PROMISEMED MEDICAL DEVICES INC. 87 13.5.1 COMPANY OVERVIEW 87 13.5.2 FINANCIAL OVERVIEW 87 13.5.3 PRODUCTS OFFERED 87 13.5.4 KEY DEVELOPMENTS 88 13.5.5 KEY STRATEGIES 88 13.6 TAECHANG INDUSTRIAL CO., LTD. 89 13.6.1 COMPANY OVERVIEW 89 13.6.2 FINANCIAL OVERVIEW 89 13.6.3 PRODUCTS OFFERED 89 13.6.4 KEY DEVELOPMENTS 89 13.6.5 KEY STRATEGIES 89 13.7 VITREX MEDICAL A/S 90 13.7.1 COMPANY OVERVIEW 90 13.7.2 FINANCIAL OVERVIEW 90 13.7.3 PRODUCTS OFFERED 90 13.7.4 KEY DEVELOPMENTS 90 13.7.5 KEY STRATEGIES 91 13.8 EMBECTA CORP. 92 13.8.1 COMPANY OVERVIEW 92 13.8.2 FINANCIAL OVERVIEW 93 13.8.3 PRODUCTS OFFERED 93 13.8.4 KEY DEVELOPMENTS 94 13.8.5 SWOT ANALYSIS 94 13.8.6 KEY STRATEGY 94 13.9 YPSOMED HOLDING AG 95 13.9.1 COMPANY OVERVIEW 95 13.9.2 FINANCIAL OVERVIEW 96 13.9.3 PRODUCTS OFFERED 96 13.9.4 KEY DEVELOPMENTS 97 13.9.5 SWOT ANALYSIS 97 13.9.6 KEY STRATEGY 97 13.10 MTD MEDICAL TECHNOLOGY AND DEVICES 98 13.10.1 COMPANY OVERVIEW 98 13.10.2 FINANCIAL OVERVIEW 99 13.10.3 PRODUCTS OFFERED 99 13.10.4 KEY DEVELOPMENTS 100 13.10.5 KEY STRATEGIES 100 13.11 OWEN MUNFORD 101 13.11.1 COMPANY OVERVIEW 101 13.11.2 FINANCIAL OVERVIEW 101 13.11.3 PRODUCTS OFFERED 101 13.11.4 KEY DEVELOPMENTS 102 13.11.5 KEY STRATEGIES 102
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD END USERLING FOR MARKET SHARE ASSESSMENT 29 TABLE 2 EUROPE: PEN NEEDLES MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 46 TABLE 3 EUROPE PEN NEEDLES MARKET, FOR STANDARD PEN NEEDLE, BY REGION, 2019–2032 (USD MILLION) 46 TABLE 4 EUROPE PEN NEEDLES MARKET, FOR SAFETY PEN NEEDLE, BY REGION, 2019–2032 (USD MILLION) 47 TABLE 5 EUROPE PEN NEEDLE MARKET, BY NEEDLE LENGTH, 2019–2032 (USD MILLION) 50 TABLE 6 EUROPE PEN NEEDLE MARKET, BY 4MM, 2019–2032 (USD MILLION) 50 TABLE 7 EUROPE PEN NEEDLE MARKET, BY 5MM, 2019–2032 (USD MILLION) 50 TABLE 8 EUROPE PEN NEEDLE MARKET, BY 6MM, 2019–2032 (USD MILLION) 51 TABLE 9 EUROPE PEN NEEDLE MARKET, BY 8MM, 2019–2032 (USD MILLION) 51 TABLE 10 EUROPE PEN NEEDLE MARKET, BY 10MM, 2019–2032 (USD MILLION) 51 TABLE 11 EUROPE PEN NEEDLE MARKET, BY 12.7MM, 2019–2032 (USD MILLION) 52 TABLE 12 EUROPE PEN NEEDLE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 55 TABLE 13 EUROPE PEN NEEDLES MARKET, BY INSULIN THERAPY, 2019–2032 (USD MILLION) 56 TABLE 14 EUROPE PEN NEEDLES MARKET, BY GLP-1 THERAPY, 2019–2032 (USD MILLION) 56 TABLE 15 EUROPE PEN NEEDLES MARKET, BY GROWTH HORMONE THERAPY, 2019–2032 (USD MILLION) 56 TABLE 16 EUROPE PEN NEEDLES MARKET, BY OSTEOPOROSIS, 2019–2032 (USD MILLION) 57 TABLE 17 EUROPE PEN NEEDLES MARKET, BY OTHERS, 2019–2032 (USD MILLION) 57 TABLE 18 EUROPE PEN NEEDLE MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) 59 TABLE 19 EUROPE PEN NEEDLES MARKET, BY DIRECT SALES, 2019–2032 (USD MILLION) 59 TABLE 20 EUROPE PEN NEEDLES MARKET, BY DISTRIBUTORS, 2019–2032 (USD MILLION) 59 TABLE 21 EUROPE PEN NEEDLE MARKET, BY END USER, 2019–2032 (USD MILLION) 62 TABLE 22 EUROPE PEN NEEDLES MARKET, BY HOSPITALS & CLINICS, 2019–2032 (USD MILLION) 62 TABLE 23 EUROPE PEN NEEDLES MARKET, BY HOMECARE SETTINGS, 2019–2032 (USD MILLION) 63 TABLE 24 EUROPE PEN NEEDLES MARKET, BY OTHERS, 2019–2032 (USD MILLION) 63 TABLE 25 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 65 TABLE 26 EUROPE: PEN NEEDLES MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 66 TABLE 27 EUROPE: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2019–2032 (USD MILLION) 66 TABLE 28 EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 66 TABLE 29 EUROPE: PEN NEEDLES MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) 67 TABLE 30 EUROPE: PEN NEEDLES MARKET, BY END USER, 2019–2032 (USD MILLION) 67 TABLE 31 FRANCE: PEN NEEDLES MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 67 TABLE 32 FRANCE: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2019–2032 (USD MILLION) 68 TABLE 33 FRANCE: PEN NEEDLES MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 68 TABLE 34 FRANCE: PEN NEEDLES MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) 68 TABLE 35 FRANCE: PEN NEEDLES MARKET, BY END USER, 2019–2032 (USD MILLION) 69 TABLE 36 REST OF EUROPE: PEN NEEDLES MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 69 TABLE 37 REST OF EUROPE: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2019–2032 (USD MILLION) 69 TABLE 38 REST OF EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 70 TABLE 39 REST OF EUROPE: PEN NEEDLES MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) 70 TABLE 40 REST OF EUROPE: PEN NEEDLES MARKET, BY END USER, 2019–2032 (USD MILLION) 70 TABLE 41 PUBLIC PLAYERS STOCK SUMMARY 74 TABLE 42 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 74 TABLE 43 PRODUCT LAUNCH/PRODUCT APPROVAL 75 TABLE 44 NOVO NORDISK A/S: PRODUCTS OFFERED 77 TABLE 45 TERUMO CORPORATION: PRODUCTS OFFERED 81 TABLE 46 TERUMO CORPORATION: KEY DEVELOPMENTS 82 TABLE 47 NIPRO EUROPE GROUP COMPANIES: PRODCUTS OFFERED 84 TABLE 48 SHANGHAI BEIPU MEDICAL CO., LTD.: PRODUCTS OFFERED 85 TABLE 49 PROMISEMED MEDICAL DEVICES INC.: PRODUCTS OFFERED 87 TABLE 50 TAECHANG INDUSTRIAL CO., LTD.: PRODCUTS OFFERED 89 TABLE 51 VITREX MEDICAL A/S: PRODCUTS OFFERED 90 TABLE 52 EMBECTA CORP.: PRODCUTS OFFERED 93 TABLE 53 YPSOMED HOLDING AG: PRODUCTS OFFERED 96 TABLE 54 MTD MEDICAL TECHNOLOGY AND DEVICES: PRODUCTS OFFERED 99 TABLE 55 MTD MEDICAL TECHNOLOGY AND DEVICES: KEY DEVELOPMENTS 100 TABLE 56 OWEN MUNFORD: PRODUCTS OFFERED 101 TABLE 57 OWEN MUNFORD:KEY DEVELOPMENTS 102   LIST OF FIGURES FIGURE 1 EUROPE PEN NEEDLE MARKET: STRUCTURE 16 FIGURE 2 EUROPE PEN NEEDLE MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 33 FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 35 FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 36 FIGURE 5 VALUE CHAIN ANALYSIS OF THE EUROPE PEN NEEDLE MARKET 38 FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: EUROPE PEN NEEDLE MARKET 40 FIGURE 7 EUROPE PEN NEEDLES MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 45 FIGURE 8 EUROPE PEN NEEDLES MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION) 45 FIGURE 9 EUROPE PEN NEEDLES MARKET SHARE (%), BY PRODUCT, 2022 46 FIGURE 10 EUROPE PEN NEEDLE MARKET, NEEDLE LENGTH SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 48 FIGURE 11 EUROPE PEN NEEDLE MARKET, BY NEEDLE LENGTH, 2022 & 2032 (USD MILLION) 49 FIGURE 12 EUROPE PEN NEEDLE MARKET SHARE (%), BY NEEDLE LENGTH, 2022 49 FIGURE 13 EUROPE PEN NEEDLE MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 53 FIGURE 14 EUROPE PEN NEEDLE MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION) 54 FIGURE 15 EUROPE PEN NEEDLE MARKET SHARE (%), BY APPLICATION, 2022 54 FIGURE 16 EUROPE PEN NEEDLE MARKET, DISTRIBUTION CHANNEL SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 58 FIGURE 17 EUROPE PEN NEEDLE MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2032 (USD MILLION) 58 FIGURE 18 EUROPE PEN NEEDLE MARKET SHARE (%), BY DISTRIBUTION CHANNEL, 2022 59 FIGURE 19 EUROPE PEN NEEDLE MARKET, END USER SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 61 FIGURE 20 EUROPE PEN NEEDLE MARKET, BY END USER, 2022 & 2032 (USD MILLION) 61 FIGURE 21 EUROPE PEN NEEDLE MARKET SHARE (%), BY END USER, 2022 62 FIGURE 22 EUROPE MARKET ANALYSIS: EUROPE PEN NEEDLES MARKET, 2019-2023(USD MILLION) 64 FIGURE 23 EUROPE: EUROPE PEN NEEDLES MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 65 FIGURE 24 EUROPE: EUROPE PEN NEEDLES MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 65 FIGURE 25 EUROPE PEN NEEDLES MARKET PLAYERS: COMPETITIVE ANALSIS, 2022 72 FIGURE 26 COMPETITOR DASHBOARD: EUROPE PEN NEEDLES MARKET 73 FIGURE 27 NOVO NORDISK A/S: FINANCIAL OVERVIEW SNAPSHOT 77 FIGURE 28 NOVO NORDISK A/S: SWOT ANALYSIS 78 FIGURE 29 TERUMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 81 FIGURE 30 TERUMO CORPORATION: SWOT ANALYSIS 82 FIGURE 31 NIPRO EUROPE GROUP COMPANIES: SWOT ANALYSIS 84 FIGURE 32 EMBECTA CORP.: FINANCIAL OVERVIEW SNAPSHOT 93 FIGURE 33 EMBECTA CORP.: SWOT ANALYSIS 94 FIGURE 34 YPSOMED HOLDING AG: FINANCIAL OVERVIEW SNAPSHOT 96 FIGURE 35 YPSOMED HOLDING AG: SWOT ANALYSIS 97 FIGURE 36 MTD MEDICAL TECHNOLOGY AND DEVICES: FINANCIAL OVERVIEW SNAPSHOT 99  

提及公司

Novo Nordisk A/STerumo CorporationEmbecta Corp.Ypsomed Holdings AGMTD Medical Technology and DevicesNovo Nordisk A/STerumo CorporationEmbecta Corp.Ypsomed Holdings AGand MTD Medical Technology and Devices.

同分類最新報告(醫療器材)

量子訊息有限公司為 Market Research Future 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們